Clinical Trials Browser

Phase 3 × Filgrastim × Plasma cell × Clear all

NCT01413178 2020-04-21

A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Phase 3 Completed

205 enrolled 11 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01146834 2019-12-27

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

Phase 3 Completed

47 enrolled 12 charts

Multiple Myeloma

NCT02489500 2018-09-10

VelRand

Phase 3 Terminated

3 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis

NCT01908621 2018-08-28

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.

Phase 3 Completed

Multiple Myeloma

NCT00477971 2016-05-17

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Phase 3 Completed

89 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

Phase 3 Completed

668 enrolled 7 charts

Multiple Myeloma, Neoplasms

NCT01301963 2014-08-06

Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide

Phase 3 Terminated

9 enrolled 7 charts

Multiple Myeloma

NCT00002599 2013-12-19

Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01998503 2013-11-29

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00028886 2013-09-17

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00004165 2012-06-06

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00008229 2010-09-21

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00932217 2009-07-03

Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

Phase 3 Unknown

Multiple Myeloma